Grantham, Mayo, Van Otterloo & Co (GMO)’s Express, Inc. EXPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,936
Closed -$417K 657
2016
Q4
$417K Sell
1,936
-2,821
-59% -$693K ﹤0.01% 426
2016
Q3
$1.12M Sell
4,757
-25,014
-84% -$6.78M 0.01% 355
2016
Q2
$8.64M Buy
29,771
+19,426
+188% +$6.52M 0.04% 241
2016
Q1
$4.43M Buy
+10,345
New +$3.71M 0.02% 307
2014
Q1
Sell
-847
Closed -$316K 658
2013
Q4
$316K Buy
847
+249
+42% +$110K ﹤0.01% 614
2013
Q3
$282K Buy
+598
New +$264K ﹤0.01% 623

Other funds holding EXPR

Grantham, Mayo, Van Otterloo & Co (GMO)'s EXPR Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Express, Inc. (EXPR) in Q1 2017, closing a stake of 1,936 shares — an estimated $417K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EXPR in Q3 2013 and held it in 6 quarters. The position peaked at $8.64M in Q2 2016. 190 funds tracked by Wall St. Rank hold EXPR as of Q1 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Express, Inc. position as of Q1 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,936 Express, Inc. shares in Q1 2017, an estimated $417K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Express, Inc. in Q3 2013 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Express, Inc. position peaked at $8.64M in Q2 2016.
  • 190 funds tracked by Wall St. Rank held Express, Inc. as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.